Celgene B.V.

Winthontlaan 2
3526 KV Utrecht
Netherlands

Phone

celgene.com

About Celgene

Product portfolio of Celgene

Product portfolio

Show all

The smart solution for filling and labeling your HPLC, cryo and micro tubes

Shaken bioreactors with in-situ gas analysis

Compact optical multi-channel oxygen reader for 96-well microplates: FirePlate-O2

News about Celgene

06-Jun-2019 | business & finance

Evotec and Celgene further expand iPSC collaboration

Evotec SE announced that its strategic alliance with Celgene Corporation (“Celgene”) has been expanded to include a new cell type triggering a payment of ...

Read news

12-Oct-2018 | business & finance

Evotec and Celgene expand iPSC collaboration to include additional cell lines

Evotec AG announced that the Company will receive a $ 6 m payment from Celgene following Celgene’s decision to expand the collaboration to include ...

Read news

07-Sep-2018 | business & finance

Evotec and Celgene enter partnership in the field of targeted protein degradation

Evotec AG announced that Evotec and Celgene Corporation have entered into a third long-term strategic drug discovery and development partnership in the ...

Read news

31-May-2018 | business & finance

Evotec and Celgene expand iPSC collaboration to include additional cell lines

Evotec AG announced that the Company will receive a $ 6 m payment from Celgene following Celgene’s decision to expand the collaboration to include ...

Read news

22-May-2018 | business & finance

Evotec and Celgene enter into strategic oncology partnership

Evotec AG announced that Evotec and Celgene Corporation have entered into a long-term strategic drug discovery and development partnership to identify new ...

Read news

16-Dec-2016 | science

Evotec and Celgene collaborate in drug discovery for neurogenerative diseases

Evotec AG announced that Evotec and Celgene Corporation have entered into a strategic drug discovery and development collaboration to identify disease- ...

Read news

16-Jul-2015 | business & finance

Celgene to Acquire Receptos

Celgene Corporation and Receptos, Inc. announced the signing of a definitive agreement in which Celgene has agreed to acquire Receptos. Under the terms of ...

Read news

19-Oct-2010 | business & finance

Celgene Completes Acquisition of Abraxis

Celgene Corporation announced it has completed its acquisition of Abraxis BioScience, Inc. For each share of Abraxis common stock, Abraxis shareholders ...

Read news

19-Nov-2009 | business & finance

Innate Pharma initiates collaboration with Celgene to evaluate the clinical potential of REVLIMID combined with IPH 2101

Innate Pharma announced that Celgene Corporationhas agreed to collaborate with Innate Pharma to evaluate the potential clinical synergy of the combination ...

Read news

08-Jul-2009 | research and development

Celgene Announces New Drug Application Filing for REVLIMID in Japan

Celgene International Sàrl announced it has filed a New Drug Application (NDA) with the Japanese Ministry of Health, Labour and Welfare (MHLW) for REVLIMID ...

Read news

26-Nov-2007 | research and development

Two major Phase III studies report oral Revlimid(R) (lenalidomide) plus dexamethasone shows increased overall survival advantage

The New England Journal of Medicine published updated data from two Phase III studies that showed a combination treatment of oral lenalidomide plus ...

Read news

04-Jan-2007 | people

Celgene Corporation Elects Sol J. Barer, Ph.D. to Chairman of the Board

Celgene Corporation announced that its Board of Directors elected Sol J. Barer, Ph.D., Chief Executive Officer, to the additional position of Chairman of ...

Read news

20-Apr-2006 | research and development

LifebankUSA(TM) Announces New Service to Bank Placental-Derived Stem Cells

LifebankUSA, a subsidiary of Celgene Cellular Therapeutics (CCT), announced plans for a new service to bank stem cells derived from the placenta. Placental ...

Read news

18-Apr-2005 | science

Celgene Corporation Reports Pluripotent Stem Cells Isolated From Placenta

Celgene Corporation announced that human placenta-derived stem cells that are "pluripotent", or have the ability to become different types of tissue, can ...

Read news

11-Jan-2005 | business & finance

Celgene Corporation Reviews 2004 Achievements and Announces 2005 Financial Outlook

Celgene Corporation today reviewed its clinical and commercial progress in 2004 and provided its initial outlook for 2005 at the J.P. Morgan 23rd Annual ...

Read news

Show more news about Celgene

Total HAMA and interference blocker